윌름스 종양 단백질 시장 : 제품 유형별, 용도별, 최종 사용자별, 검출 방법별, 병기별, 지역별
Wilms Tumor Protein Market, By Product Type, By Application, By End User, By Detection Method, By Disease Stage, By Geography
상품코드
:
1741106
리서치사
:
Coherent Market Insights
발행일
:
2025년 03월
페이지 정보
:
영문
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
윌름스 종양 단백질 시장은 2025년에는 31억 9,000만 달러로 추정되고, 2032년에는 43억 7,000만 달러에 이를 것으로 예측되며, 2025년부터 2032년에 걸쳐 CAGR 4.6%를 나타낼 전망입니다.
| 보고 범위 |
보고서 세부정보 |
| 기준 연도 |
2024년 |
시장 규모(2025년) |
31억 9,000만 달러 |
| 실적 데이터 |
2020-2024년 |
예측 기간 |
2025-2032년 |
| 예측 기간 : 2025-2032년 CAGR : |
4.60% |
가치 예측(2032년) |
43억 7,000만 달러 |
윌름스 종양 단백질은 다양한 유형의 암 진행에 중요한 역할을 하는 전사 인자입니다. NCBI에 따르면, 윌름스 종양 단백질은 염색질 리모델링 복합체에 관여하고 다수의 유전자 발현을 촉진합니다.
시장 역학 :
세계의 암 환자 증가가 예측 기간 중의 세계의 윌름스 종양 단백질 시장 성장을 가속할 것으로 전망됩니다. 2020년 1월에 발표한 데이터에 의하면, 윌름스 종양은 소아에게 보여지는 신장암의 주류입니다. 미국에서는 매년, 500-600례의 윌름스 종양이 새롭게 보고되고 있어, 이 숫자는 장기간에 걸쳐 비교적 안정된 레벨을 나타내고 있습니다.
그러나 진단과 치료에 드는 비용이 높기 때문에 예측 기간 동안 세계의 윌름스 종양 단백질 시장의 성장이 방해받을 것으로 전망됩니다. 제한된 지역에서는 환자의 접근을 제한 할 수 있습니다.이러한 비용 장벽은 윌름 종양 단백질 관련 치료법 및 진단 방법에 대한 환자의 섭취를 감소시킬 수 있으며, 잠재적으로 시장 확대에 영향을 미치고보다 광범위한 환자 집단에 도달 할 수 있는 능력을 방해할 수 있습니다.
본 조사의 주요 특징
- 본 보고서에서는 세계의 윌름스 종양 단백질 시장을 상세하게 분석했으며, 2024년을 기준연도로 한 예측 기간(2025-2032년) 시장 규모 및 복합 연간 성장률(CAGR%)을 제공합니다.
- 또, 다양한 부문에 걸친 잠재적인 수익 기회를 해명해, 이 시장의 매력적인 투자 제안의 매트릭스에 대해서 설명하고 있습니다.
- 또한 시장 성장 촉진요인, 억제요인, 기회, 신제품의 상시나 승인, 시장 동향, 지역별 전망, 주요 기업이 채용하는 경쟁 전략 등에 관한 중요한 인사이트도 제공합니다.
- 기업 하이라이트, 제품 포트폴리오, 주요 하이라이트, 재무 실적, 전략 등의 파라미터에 근거해, 세계의 윌름스 종양 단백질 시장 주요 기업 프로파일을 제공합니다.
- 이 보고서로부터의 인사이트은 마케팅 담당자나 기업의 경영진이, 향후 제품 발매, 유형 업그레이드, 시장 확대, 마케팅 전술에 관한 정보에 근거한 의사 결정을 실시하는 것을 가능하게 합니다.
- 세계의 윌름스 종양 단백질 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통 업체, 신규 진출자, 재무 분석가 등이 업계의 다양한 이해 관계자를 대상으로 합니다.
- 이해관계자는 세계의 윌름스 종양 단백질 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정이 용이해집니다.
목차
제1장 조사의 목적과 전제조건
제2장 시장 전망
- 보고서 설명
- 주요 요약
- 일관된 기회 맵(COM)
제3장 시장 역학, 규제, 동향 분석
- 시장 역학
- 윌름스 종양 치료에 있어서의 표적 요법 수요 증가
- 암 진단 및 치료 분야의 기술 개발
- 높은 진단과 치료 비용
- 윌름스 종양의 조사에의 자금 제공 증가
- 영향 분석
- 주요 하이라이트
- 규제 시나리오
- 제품 출시/승인
- PEST 분석
- PORTER 분석
- 합병과 인수 시나리오
제4장 세계의 윌름스 종양 단백질 시장 - 코로나바이러스(COVID-19) 팬데믹의 영향
- COVID-19 역학
- 공급측과 수요측의 분석
- 경제에 미치는 영향
제5장 세계의 윌름스 종양 단백질 시장, 제품 유형별(2020-2032년)
제6장 세계의 윌름스 종양 단백질 시장, 용도별(2020-2032년)
제7장 세계의 윌름스 종양 단백질 시장, 최종 사용자별(2020-2032년)
제8장 세계의 윌름스 종양 단백질 시장, 검출 방법별(2020-2032년)
- 면역조직화학(IHC)
- 효소 결합 면역 흡착 분석(ELISA)
- 웨스턴 블로팅
- 중합효소 연쇄반응(PCR)
- 기타
제9장 세계의 윌름스 종양 단백질 시장, 병기별(2020-2032년)
제10장 세계의 윌름스 종양 단백질 시장, 지역별(2020-2032년)
- 북미
- 유럽
- 영국
- 독일
- 이탈리아
- 프랑스
- 스페인
- 러시아
- 기타 유럽
- 아시아태평양
- 중국
- 인도
- 일본
- ASEAN
- 호주
- 한국
- 기타 아시아태평양
- 라틴아메리카
- 중동
- 아프리카
제11장 경쟁 구도
- Abcam plc.
- Thermo Fisher Scientific, Inc.
- Santa Cruz Biotechnology, Inc.
- Novus Biologicals, LLC
- R&D Systems, Inc.(a subsidiary of Bio-Techne Corporation)
- OriGene Technologies, Inc.
- Cell Signaling Technology, Inc.
- Merck KGaA
- BioLegend, Inc.
- Genetex, Inc.(a subsidiary of Novus Biologicals, LLC)
- Agilent Technologies, Inc.
- Proteintech Group, Inc.
- Sino Biological Inc.
- Boster Biological Technology
- Fitzgerald Industries International
제12장 섹션
KTH
영문 목차
Wilms Tumor Protein Market is estimated to be valued at USD 3.19 Bn in 2025 and is expected to reach USD 4.37 Bn by 2032, growing at a compound annual growth rate (CAGR) of 4.6% from 2025 to 2032.
| Report Coverage |
Report Details |
| Base Year: |
2024 |
Market Size in 2025: |
USD 3.19 Bn |
| Historical Data for: |
2020 To 2024 |
Forecast Period: |
2025 To 2032 |
| Forecast Period 2025 to 2032 CAGR: |
4.60% |
2032 Value Projection: |
USD 4.37 Bn |
Wilms tumor protein is a transcription factor that plays an important role in the progression of various types of cancer. It has also been shown to be associated with resistance to chemotherapies. As a result, Wilms tumor protein has been proposed to be a promising target for the development of new anti-cancer drugs. According to NCBI, Wilms tumor protein is involved in the chromatin remodeling complex and promotes the expression of several genes. It has been shown to interact with several chemotherapeutic agents including daunorubicin and mitoxantrone.
Market Dynamics:
Increasing cancer cases worldwide is expected to drive growth of the global wilms tumor protein market over the forecast period. Moreover, increasing awareness regarding Wilms tumor and its treatment and diagnosis is also expected to propel growth of the global Wilms tumor protein market over the forecast period. According to the data published by American Cancer Society in January 2020, Wilms tumor stands as the predominant form of kidney cancer found in children. Annually, in the U.S., 500 to 600 new Wilms tumor cases are reported, a figure that has exhibited relatively consistent levels over an extended period. Wilms tumors account for approximately 5% of all childhood cancer cases.
However, high cost of diagnosis and treatment procedures is expected to hinder growth of the global Wilms tumor protein market over the forecast period. The high cost of diagnosis and treatment procedures can significantly hinder the growth of the global Wilms tumor protein market. Expensive diagnostic tests and treatments may limit accessibility for patients, particularly in regions with limited healthcare resources. This cost barrier could reduce patient uptake of Wilms tumor protein-related therapies and diagnostics, potentially impacting the market's expansion and inhibiting the ability to reach a broader patient population.
Key features of the study:
- This report provides in-depth analysis of the global wilms tumor protein market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global wilms tumor protein market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Abcam plc, Thermo Fisher Scientific, Inc., Santa Cruz Biotechnology, Inc., Novus Biologicals, LLC, R&D Systems, Inc. (a subsidiary of Bio-Techne Corporation), OriGene Technologies, Inc., Cell Signaling Technology, Inc., Merck KGaA, BioLegend, Inc., Genetex, Inc. (a subsidiary of Novus Biologicals, LLC), Agilent Technologies, Inc., Proteintech Group, Inc., Sino Biological Inc., Boster Biological Technology, and Fitzgerald Industries International
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- Global wilms tumor protein market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global wilms tumor protein market
Global Wilms Tumor Protein Market Detailed Segmentation:
- By Product Type:
- Antibodies
- Assay Kits
- Recombinant Proteins
- Others
- By Application:
- Cancer Diagnosis
- Cancer Treatment
- Research and Development
- Others
- By End User:
- Hospitals
- Diagnostic Laboratories
- Research Institutes
- Others
- By Detection Method:
- Immunohistochemistry (IHC)
- Enzyme-Linked Immunosorbent Assay (ELISA)
- Western Blotting
- Polymerase Chain Reaction (PCR)
- Others
- By Disease Stage:
- Diagnosis
- Monitoring and Prognosis
- By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
- Company Profiles:
- Abcam plc
- Thermo Fisher Scientific, Inc.
- Santa Cruz Biotechnology, Inc.
- Novus Biologicals, LLC
- R&D Systems, Inc. (a subsidiary of Bio-Techne Corporation)
- OriGene Technologies, Inc.
- Cell Signaling Technology, Inc.
- Merck KGaA
- BioLegend, Inc.
- Genetex, Inc. (a subsidiary of Novus Biologicals, LLC)
- Agilent Technologies, Inc.
- Proteintech Group, Inc.
- Sino Biological Inc.
- Boster Biological Technology
- Fitzgerald Industries International
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Wilms Tumor Protein, By Product Type
- Market Wilms Tumor Protein, By Application
- Market Wilms Tumor Protein, By End User
- Market Wilms Tumor Protein, By Detection Method
- Market Wilms Tumor Protein, By Disease Stage
- Market Wilms Tumor Protein, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Increasing demand for targeted therapies for Wilms tumor treatment
- Technological developments in the field of cancer diagnostics and treatment
- High cost of diagnosis and treatment procedures
- Growing funding for research on Wilms tumor
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
4. Global Wilms Tumor Protein Market- Impact of Coronavirus (COVID-19) Pandemic
- COVID-19 Epidemiology
- Supply Side and Demand Side Analysis
- Economic Impact
5. Global Wilms Tumor Protein Market, By Product Type, 2020-2032, (US$ Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Antibodies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
- Assay Kits
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
- Recombinant Proteins
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
6. Global Wilms Tumor Protein Market, By Application, 2020-2032, (US$ Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Cancer Diagnosis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
- Cancer Treatment
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
- Research and Development
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
7. Global Wilms Tumor Protein Market, By End User, 2020-2032, (US$ Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
- Diagnostic Laboratories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
- Research Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
8. Global Wilms Tumor Protein Market, By Detection Method, 2020-2032, (US$ Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Immunohistochemistry (IHC)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,( US$ Bn)
- Enzyme-Linked Immunosorbent Assay (ELISA)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
- Western Blotting
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
- Polymerase Chain Reaction (PCR)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
9. Global Wilms Tumor Protein Market, By Disease Stage, 2020-2032, (US$ Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Diagnosis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
- Monitoring and Prognosis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
10. Global Wilms Tumor Protein Market, By Region, 2020-2032, (US$ Bn)
- Introduction
- Market Share Analysis, By Region, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, For Region, 2025-2032
- Country Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Detection Method, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Stage, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Detection Method, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Stage, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Detection Method, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Stage, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Detection Method, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Stage, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Detection Method, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Stage, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Detection Method, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Stage, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Sub-Region, 2020-2032, (US$ Bn)
- North Africa
- Central Africa
- South Africa
11. Competitive Landscape
- Abcam plc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Thermo Fisher Scientific, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Santa Cruz Biotechnology, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Novus Biologicals, LLC
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- R&D Systems, Inc. (a subsidiary of Bio-Techne Corporation)
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- OriGene Technologies, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Cell Signaling Technology, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Merck KGaA
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- BioLegend, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Genetex, Inc. (a subsidiary of Novus Biologicals, LLC)
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Agilent Technologies, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Proteintech Group, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Sino Biological Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Boster Biological Technology
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Fitzgerald Industries International
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Analyst Views
12. Section
- Research Methodology
- About us
관련자료
